-
1997
Company Description
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer.
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.
-
Manufacturer:
Science and Engineering -
Formed:
1997 -
Company Website:
-
Company E-mail:
-
Company Address:
P.O. Box 110307 2 Triangle Drive Research Triangle ParkDurham, NCUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits